Merck introduces new vaccine to swine product portfolio

IARN — At this year’s World Pork Expo, Merck Animal Health announced a new addition to its swine health product portfolio. CIRCUMVENT CML is the first and only combination vaccine shown to be effective for the vaccination of healthy swine three weeks or older against disease caused by Porcine Circovirus Types 2a and 2d, Mycoplasma hyopneumoniae, and Lawsonia intracellularis. Dr. Brett O’Brien, swine technical services manager, said the product will help producers maximize time and labor efficiency while protecting herd health.

For more on this story, visit the Iowa Agribusiness Radio Network.



Local News